{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T10:45:30Z","timestamp":1782989130205,"version":"3.54.5"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":586,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Roche Diagnostics K.K. and Fuji Film Toyama Chemical Co. Ltd."}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Low-density lipoprotein cholesterol (LDL-C), anaemia and low platelets have been associated with worse clinical outcomes in heart failure patients. We investigated the relationship between the combination of these three components and clinical outcome in patients with heart failure with preserved ejection fraction (HFpEF).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We examined the data of 1021 patients with HFpEF hospitalized with acute decompensated heart failure (HF) from the PURSUIT-HFpEF registry, a prospective, multicenter observational study. The enrolled patients were classified into four groups by an LEP (LDL-C, Erythrocyte, and Platelet) score of 0 to 3 points, with 1 point each for LDL-C, erythrocyte and platelet values less than the cut-off values as calculated by receiver operating characteristic curve analysis. The endpoint, a composite of all-cause death and HF readmission, was evaluated among the four groups. Median follow-up duration was 579 [300, 978] days. Risk of the composite endpoint significantly differed among the four groups (P &amp;lt; 0.001). Kaplan\u2013Meier analysis showed that the groups with an LEP score of 2 had higher risk of the composite endpoint than those with an LEP score of 0 or 1 (P &amp;lt; 0.001, and P = 0.013, respectively), while those with an LEP score of 3 had higher risk than those with an LEP score of 0, 1 or 2 (P &amp;lt; 0.001, P &amp;lt; 0.001 and P = 0.020, respectively). Cox proportional hazards analysis showed that an LEP score of 3 was significantly associated with the composite endpoint (P = 0.030). Kaplan\u2013Meier analysis showed that risk of the composite of all-cause death and HF readmission was significantly higher in low LDL values (less than the cut-off values as calculated by receiver operating characteristic curve analysis) patients with statin use than in those without statin use (log rank P = 0.002).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>LEP score, which comprehensively reflects extra-cardiac co-morbidities, is significantly associated with clinical outcomes in HFpEF patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.14734","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T03:19:31Z","timestamp":1709867971000},"page":"1758-1766","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Low-Density Lipoprotein Cholesterol, Erythrocyte, and Platelet in Heart Failure with Preserved Ejection Fraction"],"prefix":"10.1093","volume":"11","author":[{"given":"Masamichi","family":"Yano","sequence":"first","affiliation":[{"name":"Division of Cardiology, Osaka Rosai Hospital , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0309-7023","authenticated-orcid":false,"given":"Masami","family":"Nishino","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Osaka Rosai Hospital , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shodai","family":"Kawanami","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Osaka Rosai Hospital , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Ukita","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Osaka Rosai Hospital , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akito","family":"Kawamura","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Osaka Rosai Hospital , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Yasumoto","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Osaka Rosai Hospital , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Tsuda","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Osaka Rosai Hospital , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naotaka","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Osaka Rosai Hospital , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuharu","family":"Matsunaga-Lee","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Osaka Rosai Hospital , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Egami","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Osaka Rosai Hospital , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Yamada","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Osaka General Medical Center , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Yasumura","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Amagasaki Chuo Hospital , Amagasaki ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Seo","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Osaka General Medical Center , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaharu","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular, Osaka Police Hospital , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akito","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Amagasaki Chuo Hospital , Amagasaki ,","place":["Japan"]},{"name":"Department of Medical Informatics, Osaka University Graduate School of Medicine , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Kawanishi City Medical Center , Kawanishi ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Tamaki","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Pulmonology, Hypertension, Nephrology, Ehime University Graduate School of Medicine , Toon ,","place":["Japan"]},{"name":"Department of Cardiology, Rinku General Medical Center , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Sotomi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisaku","family":"Nakatani","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shungo","family":"Hikoso","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine , Osaka ,","place":["Japan"]},{"name":"Department of Cardiovascular Medicine, Nara Medical University , Nara ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Sakata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Osaka CardioVascular Conference (OCVC)-Heart Failure Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,8]]},"reference":[{"key":"2026012113031963700_ehf214734-bib-0001","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1056\/NEJMoa051530","article-title":"Outcome of heart failure with preserved ejection fraction in a population-based study","volume":"355","author":"Bhatia","year":"2006","journal-title":"N Engl J Med"},{"key":"2026012113031963700_ehf214734-bib-0002","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s00392-020-01633-w","article-title":"Therapeutic approaches in heart failure with preserved ejection fraction: Past, present, and future","volume":"109","author":"Wintrich","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"2026012113031963700_ehf214734-bib-0003","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.026301","article-title":"Lowering uric acid may improve prognosis in patients with hyperuricemia and heart failure with preserved ejection fraction","volume":"11","author":"Nishino","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2026012113031963700_ehf214734-bib-0004","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ijcard.2022.06.061","article-title":"Clinical impact of blood urea nitrogen, regardless of renal function, in heart failure with preserved ejection fraction","volume":"363","author":"Yano","year":"2022","journal-title":"Int J Cardiol"},{"key":"2026012113031963700_ehf214734-bib-0005","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1002\/ehf2.13350","article-title":"High density lipoprotein cholesterol\/C reactive protein ratio in heart failure with preserved ejection fraction","volume":"8","author":"Yano","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2026012113031963700_ehf214734-bib-0006","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1016\/j.jacc.2003.07.016","article-title":"The relationship between cholesterol and survival in patients with chronic heart failure","volume":"42","author":"Rauchhaus","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026012113031963700_ehf214734-bib-0007","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.jacc.2011.04.040","article-title":"Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival","volume":"58","author":"Okonko","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026012113031963700_ehf214734-bib-0008","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1093\/eurheartj\/ehad296","article-title":"Iron deficiency as a promoter of cadmium-induced cardiotoxicity","volume":"44","author":"Cirovic","year":"2023","journal-title":"Eur Heart J"},{"key":"2026012113031963700_ehf214734-bib-0009","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1093\/eurheartj\/ehad297","article-title":"Iron deficiency as a promoter of cardiotoxicity: not only cadmium-induced","volume":"44","author":"Savarese","year":"2023","journal-title":"Eur Heart J"},{"key":"2026012113031963700_ehf214734-bib-0010","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2020.100864","article-title":"Iron in infection and immunity","volume":"75","author":"Nairz","year":"2020","journal-title":"Mol Aspects Med"},{"key":"2026012113031963700_ehf214734-bib-0011","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2311262120","article-title":"Could iron deficiency potentiate the appearance of complications in influenza a virus infection?","volume":"120","author":"Cirovic","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026012113031963700_ehf214734-bib-0012","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1253\/circj.CJ-18-0961","article-title":"Incremental prognostic value of platelet count in patients with acute heart failure - A retrospective observational study","volume":"83","author":"Yamaguchi","year":"2019","journal-title":"Circ J"},{"key":"2026012113031963700_ehf214734-bib-0013","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12882-021-02579-5","article-title":"Thrombocytopenia predicts mortality in Chinese hemodialysis patients - An analysis of the China DOPPS","volume":"23","author":"Zhao","year":"2022","journal-title":"BMC Nephrol"},{"key":"2026012113031963700_ehf214734-bib-0014","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/S0140-6736(96)07015-8","article-title":"Wasting as independent risk factor for mortality in chronic heart failure","volume":"349","author":"Anker","year":"1997","journal-title":"Lancet"},{"key":"2026012113031963700_ehf214734-bib-0015","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/S0140-6736(00)02690-8","article-title":"The endotoxin-lipoprotein hypothesis","volume":"356","author":"Rauchhaus","year":"2000","journal-title":"Lancet"},{"key":"2026012113031963700_ehf214734-bib-0016","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-038294","article-title":"Study protocol for the PURSUIT-HFpEF study: A prospective, multicenter, observational study of patients with heart failure with preserved ejection fraction","volume":"10","author":"Suna","year":"2020","journal-title":"BMJ Open"},{"key":"2026012113031963700_ehf214734-bib-0017","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1056\/NEJM197112232852601","article-title":"The natural history of congestive heart failure: The Framingham study","volume":"285","author":"McKee","year":"1971","journal-title":"N Engl J Med"},{"key":"2026012113031963700_ehf214734-bib-0018","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/ejhf.1741","article-title":"How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: A consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)","volume":"22","author":"Pieske","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2026012113031963700_ehf214734-bib-0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"2026012113031963700_ehf214734-bib-0020","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1093\/eurheartj\/ehz835","article-title":"Sex differences in heart failure","volume":"40","author":"Lam","year":"2019","journal-title":"Eur Heart J"},{"key":"2026012113031963700_ehf214734-bib-0021","doi-asserted-by":"publisher","first-page":"4406","DOI":"10.1093\/eurheartj\/ehac481","article-title":"Dapagliflozin for heart failure according to body mass index: The DELIVER trial","volume":"43","author":"Adamson","year":"2022","journal-title":"Eur Heart J"},{"key":"2026012113031963700_ehf214734-bib-0022","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1016\/j.jacc.2016.08.048","article-title":"Heart failure with preserved ejection fraction and atrial fibrillation: Vicious twins","volume":"68","author":"Kotecha","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026012113031963700_ehf214734-bib-0023","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1161\/CIRCHEARTFAILURE.109.932996","article-title":"Factors associated with outcome in heart failure with preserved ejection fraction: Findings from the irbesartan in heart failure with preserved ejection fraction study (I-PRESERVE)","volume":"4","author":"Komajda","year":"2011","journal-title":"Circ Heart Fail"},{"key":"2026012113031963700_ehf214734-bib-0024","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014716","article-title":"Serum albumin is a marker of myocardial fibrosis, adverse pulsatile aortic hemodynamics, and prognosis in heart failure with preserved ejection fraction","volume":"9","author":"Prenner","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2026012113031963700_ehf214734-bib-0025","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.amjcard.2017.12.012","article-title":"Long-term prognostic significance of plasma B-type natriuretic peptide level in patients with acute heart failure with reduced, mid-range, and preserved ejection fractions","volume":"121","author":"Hamatani","year":"2018","journal-title":"Am J Cardiol"},{"key":"2026012113031963700_ehf214734-bib-0026","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0201836","article-title":"High-sensitivity C-reactive protein in heart failure with preserved ejection fraction","volume":"13","author":"DuBrock","year":"2018","journal-title":"PLoS ONE"},{"key":"2026012113031963700_ehf214734-bib-0027","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1515\/CCLM.1999.059","article-title":"Reduction of circulating cholesterol and apolipoprotein levels during sepsis","volume":"37","author":"Fraunberger","year":"1999","journal-title":"Clin Chem Lab Med"},{"key":"2026012113031963700_ehf214734-bib-0028","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155659","article-title":"Ferroptosis, a new pathogenetic mechanism in cardiometabolic diseases and cancer: Is there a role for statin therapy?","volume":"146","author":"Sahebkar","year":"2023","journal-title":"Metabolism"},{"key":"2026012113031963700_ehf214734-bib-0029","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1093\/eurheartj\/ehn205","article-title":"Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients","volume":"29","author":"van derMeer","year":"2008","journal-title":"Eur Heart J"},{"key":"2026012113031963700_ehf214734-bib-0030","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2967\/jnumed.111.095786","article-title":"Cardiac mortality assessment improved by evaluation of cardiac sympathetic nerve activity in combination with hemoglobin and kidney function in chronic heart failure patients","volume":"53","author":"Doi","year":"2012","journal-title":"J Nucl Med"},{"key":"2026012113031963700_ehf214734-bib-0031","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210200","article-title":"Impacts of demographic and laboratory parameters on key hematological indices in an adult population of southern Taiwan: A cohort study","volume":"13","author":"Wang","year":"2018","journal-title":"PLoS ONE"},{"key":"2026012113031963700_ehf214734-bib-0032","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/stem.5530140711","article-title":"The physiology of platelet production","volume":"14","author":"Kuter","year":"1996","journal-title":"Stem Cells"},{"key":"2026012113031963700_ehf214734-bib-0033","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ccl.2021.12.008","article-title":"Cardiac cachexia revisited: The role of wasting in heart failure","volume":"40","author":"Valentova","year":"2022","journal-title":"Cardiol Clin"},{"key":"2026012113031963700_ehf214734-bib-0034","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1055\/s-0037-1613404","article-title":"Inhibition of platelet activation in congestive heart failure by aldosterone receptor antagonism and ACE inhibition","volume":"89","author":"Sch\u00e4fer","year":"2003","journal-title":"Thromb Haemost"},{"key":"2026012113031963700_ehf214734-bib-0035","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"2026012113031963700_ehf214734-bib-0036","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1253\/circj.CJ-18-0639","article-title":"Effect of statins on mortality in heart failure with preserved ejection fraction without coronary artery disease - Report from the JASPER study","volume":"83","author":"Marume","year":"2019","journal-title":"Circ J"},{"key":"2026012113031963700_ehf214734-bib-0037","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S1388-9842(02)00026-0","article-title":"Whole blood impedance aggregometry for the assessment of platelet function in patients with congestive heart failure (EPCOT trial)","volume":"4","author":"Serebruany","year":"2002","journal-title":"Eur J Heart Fail"},{"key":"2026012113031963700_ehf214734-bib-0038","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1097\/00005344-199118041-00007","article-title":"Comparison of the effects of carvedilol, propranolol, and verapamil on in vitro platelet function in healthy volunteers","volume":"18","author":"Gasser","year":"1991","journal-title":"J Cardiovasc Pharmacol"},{"key":"2026012113031963700_ehf214734-bib-0039","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1023\/A:1012750430056","article-title":"Angiotensin receptor blocker losartan suppresses platelet activity by interfering with thromboxane signaling","volume":"15","author":"Schwemmer","year":"2001","journal-title":"Cardiovasc Drugs Ther"},{"key":"2026012113031963700_ehf214734-bib-0040","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1684\/abc.2007.0030","article-title":"NT-proBNP measurement on Immulite 2500 (DPC): Analytical performance and comparison with Roche diagnostics and Dade-Behring NT-proBNP immunoassays","volume":"65","author":"Cauliez","year":"2007","journal-title":"Ann Biol Clin (Paris)"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/11\/3\/1758\/64070496\/eschf_11_3_1758.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/11\/3\/1758\/64070496\/eschf_11_3_1758.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:03:30Z","timestamp":1769018610000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/11\/3\/1758\/8234060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,8]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3,8]]},"published-print":{"date-parts":[[2024,6,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.14734","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,6]]},"published":{"date-parts":[[2024,3,8]]},"assertion":[{"value":"2023-10-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}